Inactive

This is a Sources Sought notice. This is not a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capabil... This is a Sources Sought notice. This is not a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of qualified sources to perform a potential requirement. Purpose and Objectives: The Centers for Disease Control and Prevention (CDC) is seeking companies capable of providing promulgated Tuberculosis (TB) laboratory services to the U.S.-Affiliated Pacific Islands (USAPI) to improve TB control and prevention. This contract will support CDC’s mission to fight disease before it reaches our borders by providing the USAPI with TB laboratory test results and training needed to accurately diagnose TB patients and prescribe appropriate medication. CDC will also use results to provide medical consultation and technical assistance to the USAPI TB programs. Period of Performance (POP): The POP for this requirement will include a base period of one-year (12 months), followed by four one-year (12 month) option periods. The total performance period will be for a total of five years (60 months) if all options are exercised. Base Year: September 25, 2020 – September 24, 2021 Option Year 1: September 25, 2021 – September 24, 2022 Option Year 2: September 25, 2022 – September 24, 2023 Option Year 3: September 25, 2023 – September 24, 2024 Option Year 4: September 25, 2024 – September 24, 2025 Capability Statement/Information Sought: Interested firms are requested to submit a capability statement, which shall include documentation of the ability to perform the requirements and information on previous successfully completed contracts for the same supplies. The respondent must also provide their DUNS number, organization name, address, points of contact, and size and type of business (e.g., 8(a), HubZone, etc., pursuant to the applicable NAICS code), and any other information that may be helpful in developing or finalizing the acquisition requirements. Please limit your responses to ten (10) pages. All responses to this notice must be submitted electronically. Facsimile responses will not be accepted. Please submit responses to Denedra Threatt, Contract Specialist, at DThreatt2@cdc.gov. Disclaimer and Important Notes: This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will not be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. Submissions will not be returned. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. See the attached draft Performance Work Statement (PWS) for additional details and instructions.